Insights

Strategic Partnership Potential Sonoma Biotherapeutics recently partnered with VEOPOZ, showcasing openness to collaborations. Exploring strategic partnership opportunities with Sonoma Biotherapeutics could be beneficial for joint product development or distribution.

Revenue Growth Prospect With a Series A financing of $75M and a revenue range of $10-50M, Sonoma Biotherapeutics demonstrates strong financial backing. Pitching solutions aligned with their core offerings can present revenue growth possibilities.

Key Personnel Changes Key executives like Dr. Eisner have departed, signaling potential organizational shifts. Engaging with new hires like Joseph R. Arron could influence decision-making on new partnerships or solutions.

Competitive Landscape Insight Compared to similar companies like Cue Biopharma and Pionyr Immunotherapeutics, Sonoma Biotherapeutics seems well-positioned with stronger revenues. Understanding their competitive edge can guide tailored sales pitches.

Technology Alignment Opportunity Sonoma Biotherapeutics utilizes technologies like Microsoft, Google Workspace, and Zoom. Offering tech solutions that complement their existing stack can enhance operational efficiency, presenting a sales opportunity.

Similar companies to Sonoma Biotherapeutics

Sonoma Biotherapeutics Tech Stack

Sonoma Biotherapeutics uses 8 technology products and services including Microsoft Word, Microsoft Excel, Google Workspace, and more. Explore Sonoma Biotherapeutics's tech stack below.

Microsoft Word
Editors
Microsoft Excel
Editors
Google Workspace
Email
Open Graph
Miscellaneous
Smartsheet
Project Management
Minitab
Visualisation Software
Zoom
Web Conferencing
Linkedin
Widgets

Media & News

Sonoma Biotherapeutics's Email Address Formats

Sonoma Biotherapeutics uses at least 1 format(s):

Sonoma Biotherapeutics Email Formats	Example	Percentage
FLast@sonomabio.com	JDoe@sonomabio.com	94%
FMiddleLast@sonomabio.com	JMichaelDoe@sonomabio.com	3%
First.Last@sonomabio.com	John.Doe@sonomabio.com	2%
Middle@sonomabio.com	Michael@sonomabio.com	1%

Frequently Asked Questions

Where is Sonoma Biotherapeutics's headquarters located?

Sonoma Biotherapeutics's main headquarters is located at 201 Haskins Way South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Sonoma Biotherapeutics's official website and social media links?

Sonoma Biotherapeutics's official website is sonomabio.com and has social profiles on LinkedIn.

How much revenue does Sonoma Biotherapeutics generate?

As of October 2024, Sonoma Biotherapeutics's annual revenue reached $15M.

What is Sonoma Biotherapeutics's SIC code NAICS code?

Sonoma Biotherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sonoma Biotherapeutics have currently?

As of October 2024, Sonoma Biotherapeutics has approximately 129 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: J. S.Chief Financial Officer: J. S.Chief Scientific Officer: J. A.. Explore Sonoma Biotherapeutics's employee directory with LeadIQ.

What industry does Sonoma Biotherapeutics belong to?

Sonoma Biotherapeutics operates in the Biotechnology Research industry.

What technology does Sonoma Biotherapeutics use?

Sonoma Biotherapeutics's tech stack includes Microsoft WordMicrosoft ExcelGoogle WorkspaceOpen GraphSmartsheetMinitabZoomLinkedin.

What is Sonoma Biotherapeutics's email format?

Sonoma Biotherapeutics's email format typically follows the pattern of . Find more Sonoma Biotherapeutics email formats with LeadIQ.

How much funding has Sonoma Biotherapeutics raised to date?

As of October 2024, Sonoma Biotherapeutics has raised $30M in funding. The last funding round occurred on Mar 28, 2023 for $30M.

Sonoma Biotherapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

Company Overview

Headquarters: 201 Haskins Way South San Francisco, California 94080 US
Website: sonomabio.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 51-200

Media & News

Funding & Financials

$30M
Sonoma Biotherapeutics has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Mar 28, 2023 in the amount of $30M.
$10M$50M
Sonoma Biotherapeutics's revenue is in the range of $10M$50M

Funding & Financials

$30M
Sonoma Biotherapeutics has raised a total of $30M of funding over 4 rounds. Their latest funding round was raised on Mar 28, 2023 in the amount of $30M.
$10M$50M
Sonoma Biotherapeutics's revenue is in the range of $10M$50M

Company Leadership

J. S.
Chief Executive Officer
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. S.
Chief Financial Officer
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A.
Chief Scientific Officer
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. G.
Vice President Of Business Development
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. K.
Vice President Regulatory
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. S.
Chief Executive Officer
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. H.
Vp, Clinical Development
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. G.
Vice President Of Business Development
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. P.
Vice President, Process And Analytical Development
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. L.
Vice President, Development Sciences
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sonoma Biotherapeutics and Millions of Other Companies
Sign up for full access to Sonoma Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Sonoma Biotherapeutics

Cue Biopharma

Theo

Ayala Pharmaceuticals

Pionyr Immunotherapeutics

Beam Therapeutics

Rodin Therapeutics

Sonoma Biotherapeutics Tech Stack

Media & News

Regeneron invests into Sonoma Biotherapeutics, Inc $45M.

VEOPOZ partners with Sonoma Biotherapeutics, Inc.

Sonoma Biotherapeutics, Inc received financing of $75M in Series A on Aug 5th '20.

Eisner left Sonoma Biotherapeutics, Inc as CMO on Apr 29th '24.

Sonoma Biotherapeutics, Inc hires Joseph R. Arron as Chief Medical Officer.

Sonoma Biotherapeutics, Inc hires Mark D. Eisner as Chief Medical Officer.

Sonoma Biotherapeutics, Inc is developing novel regulatory T cell therapies.

Sonoma Biotherapeutics's Email Address Formats

Frequently Asked Questions

Where is Sonoma Biotherapeutics's headquarters located?

What is Sonoma Biotherapeutics's official website and social media links?

How much revenue does Sonoma Biotherapeutics generate?

What is Sonoma Biotherapeutics's SIC code NAICS code?

How many employees does Sonoma Biotherapeutics have currently?

What industry does Sonoma Biotherapeutics belong to?

What technology does Sonoma Biotherapeutics use?

What is Sonoma Biotherapeutics's email format?

How much funding has Sonoma Biotherapeutics raised to date?

Sonoma Biotherapeutics

Company Overview

Media & News

Regeneron invests into Sonoma Biotherapeutics, Inc $45M.

VEOPOZ partners with Sonoma Biotherapeutics, Inc.

Sonoma Biotherapeutics, Inc received financing of $75M in Series A on Aug 5th '20.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?